Nyse | The Truth About Skin Care

{ Tag Archives } Nyse

Smith & Nephew Highlights The ALLEVYN(TM) Difference At Symposium On Advanced Wound Care

The Advanced Wound Management Division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc (LSE: SN; NYSE: SNN) invites those attending the upcoming Symposium on Advanced Wound Care to visit the Smith & Nephew booth 301, to see the ALLEVYN™ difference with its unique triple-action technology and dynamic moisture control…

Also tagged Action Technology, Advanced Wound Care, Amp, Lse, Management Division, Moisture Control, Plc, Smith Nephew, Sn, Snn, Subsidiary, Symposium, Wound Management

2010 04 17 Skin Care News Comments Off

ULURU Inc. To Present Altrazeal(TM) Clinical Evidence At The 2010 American Professional Wound Care Association (APWCA) National Clinical Conference

ULURU Inc. (NYSE ULU) announced that the Company will be presenting clinical data at the 2010 American Professional Wound Care Association(APWCA) National Conference in Philadelphia, PA April 8-11, 2010. At the conference, Altrazeal™ clinical evidence, best clinical practices, and advanced clinical applications will be showcased in both podium and poster presentations. Dr…

Also tagged Apwca, Clinical Applications, Clinical Evidence, Clinical Practices, Philadelphia Pa, Podium, Poster Presentations, Professional Association, Ulu, Uluru, Uluru Inc, Wound Care

2010 04 10 Skin Care News Comments Off

Gauze-based NPWT Capable Of Achieving Same Treatment Goals As Foam-based NPWT

The Advanced Wound Management Division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew Plc (LSE: SN; NYSE: SNN), highlighted the results of a multi-center study which demonstrates that gauze-based Negative Pressure Wound Therapy (NPWT) achieves many of the common treatment goals defined for foam-based NPWT systems. These goals include a reduction in [...]

Also tagged Achieving Goals, Amp, Exudate, Gauze, Lse, Management Division, Smith Nephew, Sn, Snn, Subsidiary, Treatment Goals, Wound Management, Wound Therapy

2009 10 24 Skin Care News Comments Off

Take Care Health Systems Expands Treatment For Skin Conditions And Minor Injuries

Take Care Health Systems, a wholly-owned subsidiary of Walgreens (NYSE:WAG) (NASDAQ:WAG) and the largest and most comprehensive provider of convenient care clinics and worksite health and wellness centers in the country, is now offering a new set of procedures for skin conditions and minor injury treatments.

Also tagged Care Clinics, Care Health, Convenient Care, Health And Wellness, Health Centers, Health Conditions, Health Systems, Health Wellness, Minor Injuries, Minor Injury, Nasdaq, Skin Care, Skin Conditions, Skin Treatments, Subsidiary, Wag, Walgreens, Wellness Centers, Worksite Wellness

2009 07 02 Skin Care News Comments Off

Health Net Offers Tips To Let The Sun Shine In, Safely

Today, June 1, kicks off Sun Safety Week, and while the sun is a fundamental, life-fueling force, Health Net Inc. (NYSE:HNT) wants to remind everyone that it’s important to remember that this standout star also is responsible for thousands of deaths annually due to skin cancer and heat-related illnesses.

Also tagged Deaths, Fundamental Life, Health Net, Health Net Inc, Health Tips, Heat Related Illnesses, Hnt, Skin Cancer, Standout, Sun Safety, Sun Shine

2009 06 02 Skin Care News Comments Off

KCI Announces FDA Clearance Of ABThera™ Open Abdomen Dressing

Kinetic Concepts, Inc. (NYSE: KCI) announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its ABThera™ Open Abdomen Dressing. Earlier this year, the FDA cleared the ABThera™ Open Abdomen Negative Pressure Therapy Unit.

Also tagged Fda, Fda Clearance, Food And Drug, Food And Drug Administration, Food And Drug Administration Fda, Kinetic Concepts Inc, Open Abdomen

2009 05 22 Skin Care News Comments Off

New Evidence Supports Efficacy And Value Of Smith & Nephew NPWT Products

Smith & Nephew Inc’s (LSE: SN; NYSE: SNN) Advanced Wound Management division announced that nine clinical posters featuring its Negative Pressure Wound Therapy (NPWT) products will be presented at next week’s Symposium on Advanced Wound Care (SAWC) and Wound Healing Society Meeting.

Also tagged Advanced Wound Care, Amp, Clinical Posters, Efficacy, Lse, Management Division, New Evidence, Sawc, Smith Nephew, Sn, Snn, Symposium, Wound Healing Society, Wound Management, Wound Therapy

2009 04 25 Skin Care News Comments Off

Altrazeal(TM) Clinical Evidence To Be Presented At The American Professional Wound Care Association (APWCA) National Clinical Conference 2009

ULURU Inc. (NYSE Alternext: ULU) announced that clinical evidence on the treatment of wounds using Altrazeal(TM) Transforming Powder Dressing, and data on the physical properties of Altrazeal(TM) Silver will be presented at the annual APWCA National Clinical Conference in Philadelphia, April 2-5, 2009. The work will be presented in podium presentations and with posters on [...]

Also tagged Alternext, Apwca, Ceo, Clinical Evidence, Philadelphia, Podium, Posters, Presentations, Professional Association, Treatment Of Wounds, Ulu, Uluru, Uluru Inc, Wound Care

2009 04 02 Skin Care News Comments Off

ULURU Inc. To Present Altrazeal(TM) Clinical Evidence And Advanced Therapeutic Research At The Diabetic Foot Global Conference (DFCon) 2009

ULURU Inc. (NYSE Alternext: ULU) announced that clinical evidence on the treatment of diabetic foot ulcers, and data on the use of its patented Nanoflex(TM) Technology for Therapeutic Delivery will be presented at the annual DFCon Global Meeting in Los Angeles, California March 19-21. The work will be presented on posters that will be on [...]

Also tagged Alternext, Angeles California, California March, Clinical Evidence, Clinical Research, Diabetic Foot Ulcers, Diabetic Ulcers, Global Conference, Global Meeting, March 19, Posters, Therapeutic Research, Ulu, Uluru, Uluru Inc

2009 03 19 Skin Care News Comments Off

Acanya(TM) Gel, A New Treatment For Moderate To Severe Acne, Launched By Coria Laboratories

Coria Laboratories, the newly expanded dermatology division of Valeant Pharmaceuticals International (NYSE: VRX), announced the commercial launch of Acanya(TM) Gel (clindamycin phosphate 1.2% and benzoyl peroxide 2.5%) indicated for the once-daily treatment of acne vulgaris in patients 12 years and older.

Also tagged Acne, Acne Vulgaris, Benzoyl Peroxide, Clindamycin, Clindamycin Phosphate, Coria Laboratories, Launch, Severe Acne, Treatment Of Acne, Valeant Pharmaceuticals International, Vrx

2009 03 07 Skin Care News Comments Off

The Truth About Skin Care

{ Tag Archives } Nyse

Smith & Nephew Highlights The ALLEVYN(TM) Difference At Symposium On Advanced Wound Care

ULURU Inc. To Present Altrazeal(TM) Clinical Evidence At The 2010 American Professional Wound Care Association (APWCA) National Clinical Conference

Gauze-based NPWT Capable Of Achieving Same Treatment Goals As Foam-based NPWT

Take Care Health Systems Expands Treatment For Skin Conditions And Minor Injuries

Health Net Offers Tips To Let The Sun Shine In, Safely

KCI Announces FDA Clearance Of ABThera™ Open Abdomen Dressing

New Evidence Supports Efficacy And Value Of Smith & Nephew NPWT Products

Altrazeal(TM) Clinical Evidence To Be Presented At The American Professional Wound Care Association (APWCA) National Clinical Conference 2009

ULURU Inc. To Present Altrazeal(TM) Clinical Evidence And Advanced Therapeutic Research At The Diabetic Foot Global Conference (DFCon) 2009

Acanya(TM) Gel, A New Treatment For Moderate To Severe Acne, Launched By Coria Laboratories

Home

Recommendations

Free Ebook

Latest News

Site Features

Get a free ebook valued at $8.95 when you sign up for our free Skincare Tips newsletter. The book The Truth About Skincare: How To Have Younger Looking Skin sells every day for $8.95 at Bargain Books Web. It's yours at no cost by immediate download when you sign up right now. You can unsubscribe any time, and the book is yours to keep.
Name:
Email: